Hualan Biological Engineering Inc. A | Ownership
Companies that own Hualan Biological Engineering Inc. A
E Fund Management Co., Ltd.
22,295,060
2.77%
14,286,946
0.77%
09/30/2017
China Life Asset Management Co., Ltd.
12,949,203
1.61%
-2,361,512
0.72%
09/30/2017
China Investment Corp. (Investment Management)
10,679,520
1.33%
0
0.15%
09/30/2017
FIL Investment Advisors (UK) Ltd.
4,959,955
0.62%
-1,235,337
0.03%
05/31/2018
Yinhua Fund Management Co., Ltd.
4,263,013
0.53%
1,129,765
0.35%
12/31/2017
FIL Investment Management (Hong Kong) Ltd.
4,237,522
0.53%
90,162
0.09%
05/31/2018
China Asset Management Co., Ltd.
3,037,506
0.38%
-2,248,902
0.08%
12/31/2017
Norges Bank Investment Management
2,137,988
0.27%
2,137,988
0%
12/31/2017
Guotai Asset Management Co., Ltd.
1,582,106
0.2%
-1,464,579
0.12%
12/31/2017
China Universal Asset Management Co., Ltd.
1,532,658
0.19%
-1,894,255
0.07%
12/31/2017
| Address |
No. 1 Hualan Avenue
Xinxiang Henan 453003
China
|
|
Employees
|
- |
| Website |
http://www.hualanbio.com |
| Updated |
07/08/2019 |
| Hualan Biological Engineering, Inc. engages in the manufacture, production, commercialization, research and development of biopharmaceutical products. It focuses on human blood products, viral vaccines, bacterial vaccines and recombinant biologics. The company was founded on March 20, 1992 and is headquartered in Xinxiang, China. |
